Now available in the U.S., RED™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood clots First catheter of new RED series expands the company’s extensive portfolio of innovative stroke products ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, […]
Other News
Fist Assist Devices, LLC Announces 510(k) Clearance for Focal Arm Massage and Increased Vein Circulation
LOS ALTOS HILLS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, has received FDA 510(k) clearance for use of the Fist Assist FA-1 device in the United States as an arm massage and increased vein circulation device and has commenced marketing the Fist Assist FA-1 device for that indication for use. “We are […]
Angel Medical Systems Announces Brad Snow as Interim Chief Executive Officer
EATONTOWN, N.J., June 22, 2021 /PRNewswire/ — Angel Medical Systems, Inc., (dba AngelMed) announced today the departure of Gordie Nye as CEO of the company effective immediately. He will be succeeded by Brad Snow, an experienced leader in the medical device industry who has served in a variety of senior roles at several successful med-tech startups. […]
Ablacon Announces Martin Grasse as CEO and Clinical Study Progress
MENLO PARK, Calif., June 22, 2021 /PRNewswire/ — Ablacon, Inc., developer of an advanced mapping system to guide the treatment of atrial fibrillation (AF), announced today that is has promoted Martin Grasse to the position of Chief Executive Officer. Former CEO Duke Rohlen will continue with the company as Executive Chairman. “Marty has demonstrated exceptional leadership capabilities […]
Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have been in the news in recent days
– Genetics allows the study of risk related to hereditary cardiovascular disease, with special relevance in cardiomyopathies, arrhythmias and vascular involvement syndromes that may involve risk of sudden death. – The myCardio service designed by Veritas Intercontinental, a company focused on the study of genetic predisposition, includes all genes recommended […]
Remote Cardiac Monitoring Leader Implicity Appoints Tim Laird as New VP of Sales North America to Enhance Leadership Team
Proven sales leader brings more than 20 years of healthcare experience to help Implicity accelerate its expansion into the US market CAMBRIDGE, Mass., June 22, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring software and cardiac data management solutions, today announced the addition of Tim Laird as Vice President of Sales–North America. Laird […]
JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing
Global Contract Research Organization (CRO) Avania to Manage All Regulatory Affairs in Connection with JanOne’s Phase 2b Trial Preparedness and Execution LAS VEGAS, June 22, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced its selection […]
BioCardia to Present CardiAMP Cell Therapy Clinical Trial Data at European Society of Cardiology Heart Failure 2021
Cell Therapy Platform Demonstrates High Dose CD34+ Cell Performance Characteristics in Patients with Ischemic Heart Failure SAN CARLOS, Calif., June 22, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces data from its CardiAMP […]
Nuwellis Announces New Appointments to Leadership Team
George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer EDEN PRAIRIE, Minn., June 22, 2021 (GLOBE NEWSWIRE) — Continuing its dynamic growth in support of its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric […]
Philips announces first patient enrollment in DEFINE GPS global multicenter study to assess superiority of PCI procedures guided by co-registered iFR and interventional angiography
June 22, 2021 First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI) procedures guided by iFR data co-registered on the angiogram (interventional X-ray image) versus the current standard of care, an angiogram alone One of the largest-ever […]
Recent
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
Rad AI Appoints Chief Operating Officer and First Chief Clinical Officer, Strengthening Operational and Clinical Strategy
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
Popular
- No commented posts yet